Christine Peters’ Post

At Teva, being all in for better health, we're using AI to advance the drug development process: Improve the speed and accuracy of diagnosing medical conditions, accelerate clinical trial processes, and more – all so that we can get medicines to patients faster. One such example is Teva's involvement in the MOBILISE-D project, which focuses on conditions that often affect mobility, such as chronic obstructive pulmonary disease (COPD) and Parkinson’s disease. As Michal Melamed, Data Scientist, Advanced Analytics and AI at Teva, explains, “We are using AI and analytics to try to predict and assess the motor stage of the patients' disease, which affects the body’s movement, and to identify the walking factors most associated with Parkinson's disease motor stages.” Find out more about Teva’s innovative work in AI: https://lnkd.in/dFiikrfT #WorldHealthDay #Innovation #AI #AIinHealthcare #Tevapharm #WeAreAllInForBetterHealth

For those working in Renal Care – CKD to ERSD, this webinar should be one of your top five things to do that day. I know it will be informative, I suspect sprinkled with humor, and offer many insightful ways organizations are leveraging artificial intelligence to improve patient care and outcomes #aiforgood

𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑳𝒂𝒃𝒐𝒓𝒂𝒕𝒐𝒓𝒚 𝑺𝒆𝒓𝒗𝒊𝒄𝒆 𝑴𝒂𝒓𝒌𝒆𝒕: 𝑫𝒓𝒊𝒗𝒊𝒏𝒈 𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏 𝒊𝒏 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝑮𝒆𝒕 𝑴𝒐𝒓𝒆 𝑰𝒏𝒇𝒐: https://lnkd.in/dBcGWHRs The global Clinical Laboratory Service Market is rapidly evolving, driven by advancements in diagnostic technologies, increasing chronic diseases, and a growing demand for early and accurate medical testing. From routine blood tests to complex molecular diagnostics, these services are crucial for effective treatment and preventive healthcare. 𝑲𝒆𝒚 𝑮𝒓𝒐𝒘𝒕𝒉 𝑫𝒓𝒊𝒗𝒆𝒓𝒔: Rising prevalence of chronic diseases like diabetes and cardiovascular disorders Expansion of personalized medicine and genomic testing Increasing investments in R&D and healthcare infrastructure Growing demand for point-of-care testing With digital transformation and the integration of AI in laboratory settings, clinical labs are now more efficient, offering faster, more reliable results. The future of healthcare diagnostics is here, revolutionizing patient care and improving outcomes. #HealthcareInnovation #LaboratoryServices #Diagnostics #ClinicalLab #PatientCare #HealthcareTech #MarketTrends #LabTesting

April 7th is World Health Day, and this year’s theme is ‘My health, my right’, championing the right of everyone, everywhere, to have access to health services, education and information. Like in so many other aspects of our lives, Artificial Intelligence (AI) and advanced analytics technologies have the potential to transform the world of healthcare. At Teva, being all in for better health, we're using AI to advance the drug development process: Improve the speed and accuracy of diagnosing medical conditions, accelerate clinical trial processes, and more – all so that we can get medicines to patients faster. One such example is Teva's involvement in the MOBILISE-D project, which focuses on conditions that often affect mobility, such as chronic obstructive pulmonary disease (COPD) and Parkinson’s disease. As Michal Melamed, Data Scientist, Advanced Analytics and AI at Teva, explains, “We are using AI and analytics to try to predict and assess the motor stage of the patients' disease, which affects the body’s movement, and to identify the walking factors most associated with Parkinson's disease motor stages.” Find out more about Teva’s innovative work in AI: https://lnkd.in/d58v9WnG #WorldHealthDay #Innovation #AI #AIinHealthcare #Tevapharm #WeAreAllInForBetterHealth

April 7th is World Health Day, and this year’s theme is ‘My health, my right’, championing the right of everyone, everywhere, to have access to health services, education and information. Like in so many other aspects of our lives, Artificial Intelligence (AI) and advanced analytics technologies have the potential to transform the world of healthcare. At Teva, being all in for better health, we're using AI to advance the drug development process: Improve the speed and accuracy of diagnosing medical conditions, accelerate clinical trial processes, and more – all so that we can get medicines to patients faster. One such example is Teva's involvement in the MOBILISE-D project, which focuses on conditions that often affect mobility, such as chronic obstructive pulmonary disease (COPD) and Parkinson’s disease. As Michal Melamed, Data Scientist, Advanced Analytics and AI at Teva, explains, “We are using AI and analytics to try to predict and assess the motor stage of the patients' disease, which affects the body’s movement, and to identify the walking factors most associated with Parkinson's disease motor stages.” Find out more about Teva’s innovative work in AI: https://lnkd.in/gbZ_ZH63 #WorldHealthDay #Innovation #AI #AIinHealthcare #Tevapharm #WeAreAllInForBetterHealth

🔬 Shaping the Future: Navigating the Regulatory Landscape for AI in Diagnostics 🔬 “We viewed the FDA as a valuable partner in the submission process,” said Prenosis CEO Bobby Reddy, Jr. at today’s #ADLM2024 Data Summit. “Its team provided crucial feedback during the review process to ensure the Sepsis ImmunoScore™ was a safe and effective diagnostic tool for sepsis. AI in healthcare must be developed responsibly, including regulatory oversight.” Reddy joined industry leaders from NorthShore University HealthSystem, Pattern Bioscience, University of Michigan Medical School, and Roche to discuss “Navigating the Changing Regulatory Landscape for AI in Clinical Diagnostics.” Bobby shared insights into the rigorous regulatory journey of the Sepsis ImmunoScore™, a groundbreaking milestone as the first FDA-authorized AI diagnostic for #sepsis. Reddy emphasized the need for #AI development to align with clinicians’ needs, ensuring transparency to build trust and foster a true clinician-AI partnership. The Sepsis ImmunoScore™ demonstrates how AI can enhance clinical insights while maintaining trust and clarity in medical diagnostics. #ClinicalDiagnostics #AIinHealthcare #SepsisAwareness

April 7th is World Health Day, and this year’s theme is ‘My health, my right’, championing the right of everyone, everywhere, to have access to health services, education and information. Like in so many other aspects of our lives, Artificial Intelligence (AI) and advanced analytics technologies have the potential to transform the world of healthcare. At Teva, being all in for better health, we're using AI to advance the drug development process: Improve the speed and accuracy of diagnosing medical conditions, accelerate clinical trial processes, and more – all so that we can get medicines to patients faster. One such example is Teva's involvement in the MOBILISE-D project, which focuses on conditions that often affect mobility, such as chronic obstructive pulmonary disease (COPD) and Parkinson’s disease. As Michal Melamed, Data Scientist, Advanced Analytics and AI at Teva, explains, “We are using AI and analytics to try to predict and assess the motor stage of the patients' disease, which affects the body’s movement, and to identify the walking factors most associated with Parkinson's disease motor stages.” Find out more about Teva’s innovative work in AI: https://lnkd.in/eMT4a4NK #WorldHealthDay #Innovation #AI #AIinHealthcare #Tevapharm #WeAreAllInForBetterHealth

April 7th is World Health Day, and this year’s theme is ‘My health, my right’, championing the right of everyone, everywhere, to have access to health services, education and information. Like in so many other aspects of our lives, Artificial Intelligence (AI) and advanced analytics technologies have the potential to transform the world of healthcare. At Teva, being all in for better health, we're using AI to advance the drug development process: Improve the speed and accuracy of diagnosing medical conditions, accelerate clinical trial processes, and more – all so that we can get medicines to patients faster. One such example is Teva's involvement in the MOBILISE-D project, which focuses on conditions that often affect mobility, such as chronic obstructive pulmonary disease (COPD) and Parkinson’s disease. As Michal Melamed, Data Scientist, Advanced Analytics and AI at Teva, explains, “We are using AI and analytics to try to predict and assess the motor stage of the patients' disease, which affects the body’s movement, and to identify the walking factors most associated with Parkinson's disease motor stages.” Find out more about Teva’s innovative work in AI: https://lnkd.in/dQDi3k9d #WorldHealthDay #Innovation #AI #AIinHealthcare #Tevapharm #WeAreAllInForBetterHealth